DMRT1 in Mammalian Sexual Development
DMRT1 in Mammalian Sexual Development
批准号:
9026212
负责人:
VIVIAN J BARDWELL
金额:
$60.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2019-11-30
关键词:
AdultBindingBinding ProteinsBinding SitesBiochemicalBiological ProcessBiologyBody partCandidate Disease GeneCell Fate ControlCellsChIP-seqChromosomesComplexDNADNA BindingDataDevelopmentDiagnosisEtiologyFailureFamilyFemaleFundingGene ExpressionGene FamilyGene TargetingGenesGenetic TranscriptionGenomic approachGerm CellsGerm LinesGonadal DisordersGonadal structureHealthHormonesHumanIn VitroInfertilityInfertility studyKnowledgeLeadLearningLogicMaintenanceMajor GrooveMalignant neoplasm of testisMedicalMedicineModelingMolecularMolecular GeneticsMusMutationOrthologous GeneOvaryPathogenesisPlayPoint MutationProcessProductionProteinsRegulatory ElementReproductionRoleSexual DevelopmentSiteSomatic CellStructureTesticular Germ Cell TumorTestingTestisTherapeuticTransgenesTretinoinVertebratesWorkalpha helixbasecell typefetalgenetic analysisgenetic regulatory proteingenome-wide analysisgenomic toolsgonadal cancergranulosa cellmalemouse modelnovelpostnatalpreventprogenitorresearch studyretinoic acid receptor alphasertoli cellsexsex determinationsex development disordersocialsperm cellstoichiometrytranscription factortranscriptometransdifferentiation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall objective of the proposed work is to understand how the Dmrt1 gene controls cell fates in the mammalian gonad. The testis has two essential functions: production of sperm, the cells that serve as vehicles for the immortality of male germ line DNA; and production of hormones that direct other parts of the body to develop in a male-specific manner. Failures of these processes cause disorders of sex development (DSD), infertility, and gonadal cancer. Dmrt1 belongs to family of conserved transcriptional regulators and controls multiple crucial processes in the mammalian testis both in germ cells and somatic cells. A recent discovery is that DMRT1 controls sexual cell fate: loss of DMRT1 in the testes causes sexual transdifferentiation of male somatic cells to their female equivalents, while expression of DMRT1 in the ovary is sufficient to reprogram female somatic cells into their male equivalents, even in adults. The central hypothesis of this proposal is that competing male and female regulatory networks are continuously required to maintain sexual cell fates and to prevent transdifferentiation. This proposal has three aims focused on a deeper understanding of how DMRT1 controls gonadal cell fate. Aim 1 asks how loss of DMRT1 allows a female regulatory network to supplant the one normally maintaining male sex, and asks through what intermediate state transdifferentiating cells transit. The main approaches will be genome-wide analysis of DNA binding by key sexual regulatory proteins, and transcriptome analysis of transdifferentiating cells. Aim 2 seeks a deeper mechanistic understanding of how DMRT1 regulates target gene transcription to control cell fate and asks how DMRT1 and the conserved male regulator SOX9 functionally interact in this process. The experiments will employ an array of state-of-the-art genomic tools to find key regulatory targets and learn by what transcriptional mechanisms DMRT1 and SOX9 control them. Aim 3 will determine how a newly discovered human DMRT1 mutation causes dominant male-to-female sex reversal, using a mouse model for human DSD. Sexual transdifferentiation is a recently discovered and still understudied biological process and its molecular basis is highly relevant to other examples of transdifferentiation and reprogramming. The proposed work has direct human health relevance: loss of DMRT1 in humans is associated with DSD including male-to-female sex reversal, as well as infertility and testicular germ cell tumors (TGCTs). As a result, the proposed work will help uncover the molecular pathogenesis of DSD and other disorders of the gonad and will inform studies of cell fate reprogramming.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of Trophoblast Differentiation in Placental Development
-
批准号:9309015
-
项目类别:
-
资助金额:$33.46万
-
财政年份:2016
-
负责人:VIVIAN J BARDWELL
-
依托单位:
Control of Trophoblast Differentiation in Placental Development
-
批准号:9922711
-
项目类别:
-
资助金额:$33.04万
-
财政年份:2016
-
负责人:VIVIAN J BARDWELL
-
依托单位:
MOLECULAR BASIS OF ACTION OF THE PUTATIVE ONCOGENE BCL6
-
批准号:2796321
-
项目类别:
-
资助金额:$10.01万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
Molecular Basis of Action of the Putative Oncogene BCL-6
-
批准号:7765615
-
项目类别:
-
资助金额:$31.11万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
MOLECULAR BASIS OF ACTION OF THE PUTATIVE ONCOGENE BCL6
-
批准号:2895602
-
项目类别:
-
资助金额:$10.41万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
Molecular Basis of Action of the Putative Oncogene BCL6
-
批准号:6622122
-
项目类别:
-
资助金额:$29.32万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
Molecular Basis of Action of the Putative Oncogene BCL-6
-
批准号:7612082
-
项目类别:
-
资助金额:$31.11万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
MOLECULAR BASIS OF ACTION OF THE PUTATIVE ONCOGENE BCL6
-
批准号:2010067
-
项目类别:
-
资助金额:$9.25万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
Molecular Basis of Action of the Putative Oncogene BCL-6
-
批准号:8034680
-
项目类别:
-
资助金额:$30.17万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
Molecular Basis of Action of the Putative Oncogene BCL6
-
批准号:6686781
-
项目类别:
-
资助金额:$29.31万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
Molecular Basis of Action of the Putative Oncogene BCL6
-
批准号:6830719
-
项目类别:
-
资助金额:$29.31万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
MOLECULAR BASIS OF ACTION OF THE PUTATIVE ONCOGENE BCL6
-
批准号:2545410
-
项目类别:
-
资助金额:$9.62万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
MOLECULAR BASIS OF ACTION OF THE PUTATIVE ONCOGENE BCL6
-
批准号:6173431
-
项目类别:
-
资助金额:$10.83万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
Molecular Basis of Action of the Putative Oncogene BCL6
-
批准号:6439136
-
项目类别:
-
资助金额:$29.33万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
Molecular Basis of Action of the Putative Oncogene BCL-6
-
批准号:8215861
-
项目类别:
-
资助金额:$30.17万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
Molecular Basis of Action of the Putative Oncogene BCL-6
-
批准号:7460374
-
项目类别:
-
资助金额:$31.12万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
Molecular Basis of Action of the Putative Oncogene BCL6
-
批准号:6997815
-
项目类别:
-
资助金额:$28.62万
-
财政年份:1996
-
负责人:VIVIAN J BARDWELL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: